{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:48:30Z","timestamp":1794376110750,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19 manifestations range from asymptomatic to life-threatening infections. The outcome in different inborn errors of immunity (IEI) is still a matter of debate. In this retrospective study, we describe the experience of the of the Italian Primary Immunodeficiencies Network (IPINet). Sixteen reference centers for adult or pediatric IEI were involved. One hundred fourteen patients were enrolled including 35 pediatric and 79 adult patients. Median age was 32\u00a0years, and male-to-female ratio was 1.5:1. The most common IEI were 22q11.2 deletion syndrome in children (26%) and common variable immunodeficiency (CVID) in adults (65%). Ninety-one patients did not require hospital admission, and among these, 33 were asymptomatic. Hospitalization rate was 20.17%. Older age (<jats:italic>p<\/jats:italic>0.004) and chronic lung disease (<jats:italic>p<\/jats:italic>0.0008) represented risk factors for hospitalization. Hospitalized patients mainly included adults suffering from humoral immunodeficiencies requiring immunoglobulin replacement therapy and as expected had lower B cell counts compared to non-hospitalized patients. Infection fatality rate in the whole cohort was 3.5%. Seroconversion was observed is 86.6% of the patients evaluated and in 83.3% of CVID patients. 16.85% of the patients reported long-lasting COVID symptoms. All but one patient with prolonged symptoms were under IgRT. The fatality rate observed in IEI was slightly similar to the general population. The age of the patients who did not survive was lower compared to the general population, and the age stratified mortality in the 50\u201360 age range considerable exceeded the mortality from 50 to 60 age group of the Italian population (14.3 vs 0.6%;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). We hypothesize that this is due to the fact that comorbidities in IEI patients are very common and usually appear early in life.<\/jats:p>","DOI":"10.1007\/s10875-022-01264-y","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T19:02:59Z","timestamp":1650481379000},"page":"935-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)"],"prefix":"10.1007","volume":"42","author":[{"given":"Giuliana","family":"Giardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Milito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Lougaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Punziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carrabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rivalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marzollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Firinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldassare","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Fabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Soresina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Cicalese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-9843","authenticated-orcid":false,"given":"Claudio","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"issue":"10229","key":"1264_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"2","key":"1264_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","volume":"147","author":"I Meyts","year":"2021","unstructured":"Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520\u201331.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1264_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/MOP.0000000000001062","volume":"33","author":"G Bucciol","year":"2021","unstructured":"Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648\u201356.","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"1264_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/ACI.0000000000000786","volume":"21","author":"SG Tangye","year":"2021","unstructured":"Tangye SG, Bucciol G, Meyts I. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2021;21(6):515\u201324.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"1264_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24\u201364.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1264_CR6","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","volume":"9","author":"C Milito","year":"2021","unstructured":"Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9(7):2904-6.e2.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"30","key":"1264_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"1264_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.15585\/mmwr.mm6926e3","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde MW, Billig Rose E, Lindsell CJ, Shapiro NI, Files DC, Gibbs KW, et al. Characteristics of adult outpatients and inpatients with COVID-19 - 11 academic medical centers, United States, March-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(26):841\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"1264_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10875-021-01066-8","volume":"41","author":"ES Goudouris","year":"2021","unstructured":"Goudouris ES, Pinto-Mariz F, Mendon\u00e7a LO, Aranda CS, Guimar\u00e3es RR, Kokron C, et al. Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study. J Clin Immunol. 2021;41(7):1479\u201389.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1264_CR10","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10875-021-01077-5","volume":"41","author":"LM Castano-Jaramillo","year":"2021","unstructured":"Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O\u2019Farrill-Romanillos PM, Muzquiz Zerme\u00f1o D, Scheffler Mendoza SC, Venegas Montoya E, et al. COVID-19 in the context of inborn errors of immunity: a case series of 31 patients from Mexico. J Clin Immunol. 2021;41(7):1463\u201378.","journal-title":"J Clin Immunol"},{"issue":"22","key":"1264_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2020.22717","volume":"324","author":"SD Datta","year":"2020","unstructured":"Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251\u20132.","journal-title":"JAMA"},{"key":"1264_CR12","doi-asserted-by":"crossref","unstructured":"Greenhalgh T, Knight M, A\u2019Court C, Buxton M, and Husain L. Management of post-acute covid-19 in primary care. Bmj. 2020;370(m3026.","DOI":"10.1136\/bmj.m3026"},{"issue":"3","key":"1264_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields AM, Burns SO, Savic S, Richter AG. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870-5.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"1264_CR14","doi-asserted-by":"crossref","unstructured":"Marcus N, Frizinsky S, Hagin D, Ovadia A, Hanna S, Farkash M, et al. Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel. Front Immunol. 2020;11(614086.","DOI":"10.3389\/fimmu.2020.614086"},{"issue":"1","key":"1264_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","volume":"9","author":"HE Ho","year":"2021","unstructured":"Ho HE, Mathew S, Peluso MJ, Cunningham-Rundles C. Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City. J Allergy Clin Immunol Pract. 2021;9(1):490-3.e2.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1264_CR16","doi-asserted-by":"crossref","unstructured":"Yilmaz Topal O, Metin A, Kulhas Celik \u0130, Metbulut AP, Alim Aydin S, Kanik Yuksek S, et al. Clinical characteristics of COVID-19 in children and young adolescents with inborn errors of immunity. Pediatr Allergy Immunol. 2022;33(1):e13661.","DOI":"10.1111\/pai.13661"},{"key":"1264_CR17","doi-asserted-by":"crossref","unstructured":"Dey\u00e0-Mart\u00ednez A, Garc\u00eda-Garc\u00eda A, Gonzalez-Navarro EA, Yiyi L, Vlagea A, Jordan I, et al. COVID-19 in children and young adults with moderate\/severe inborn errors of immunity in a high burden area in pre-vaccine era. Clin Immunol. 2021;230(108821.","DOI":"10.1016\/j.clim.2021.108821"},{"issue":"3","key":"1264_CR18","first-page":"77","volume":"10","author":"N Moazzen","year":"2021","unstructured":"Moazzen N, Ahanchian H, Aelami MH, Asiyon H, Astaneh M, Naeimi AM, et al. COVID-19 in children with inborn errors of immunity: clinical scenarios. Am J Clin Exp Immunol. 2021;10(3):77\u201385.","journal-title":"Am J Clin Exp Immunol"},{"issue":"4","key":"1264_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/bjh.16699","volume":"189","author":"L Sainati","year":"2020","unstructured":"Sainati L, Biffi A. How we deal with the COVID-19 epidemic in an Italian paediatric onco-haematology clinic located in a region with a high density of cases. Br J Haematol. 2020;189(4):640\u20132.","journal-title":"Br J Haematol"},{"issue":"7","key":"1264_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22(7):829\u201338.","journal-title":"Nat Immunol"},{"key":"1264_CR21","doi-asserted-by":"crossref","unstructured":"Puoti MG, Rybak A, Kiparissi F, Gaynor E, and Borrelli O. SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr. 2021;9(617980.","DOI":"10.3389\/fped.2021.617980"},{"issue":"23","key":"1264_CR22","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.3748\/wjg.v27.i23.3303","volume":"27","author":"C Calitri","year":"2021","unstructured":"Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, et al. Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: a comprehensive review. World J Gastroenterol. 2021;27(23):3303\u201316.","journal-title":"World J Gastroenterol"},{"key":"1264_CR23","doi-asserted-by":"crossref","unstructured":"Ricci S, Lodi L, Serranti D, Moroni M, Belli G, Mancano G, et al. Immunological features of neuroblastoma amplified sequence deficiency: report of the first case identified through newborn screening for primary immunodeficiency and review of the literature. Front Immunol. 2019;10(1955.","DOI":"10.3389\/fimmu.2019.01955"},{"issue":"18","key":"1264_CR24","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775\u20136.","journal-title":"JAMA"},{"issue":"6","key":"1264_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603\u20135.","journal-title":"JAMA"},{"issue":"4","key":"1264_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.7326\/M20-5661","volume":"174","author":"V Chopra","year":"2021","unstructured":"Chopra V, Flanders SA, O\u2019Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1264_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jaci.2021.10.031","volume":"149","author":"LK Brown","year":"2022","unstructured":"Brown LK, Moran E, Goodman A, Baxendale H, Bermingham W, Buckland M, et al. Treatment of chronic or relapsing COVID-19 in immunodeficiency. J Allergy Clin Immunol. 2022;149(2):557-61.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"1264_CR28","doi-asserted-by":"crossref","unstructured":"Palomba E, Carrabba M, Zuglian G, Alagna L, Saltini P, Fortina V, et al. Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia. Int J Infect Dis. 2021;110(338\u201340.","DOI":"10.1016\/j.ijid.2021.07.064"},{"key":"1264_CR29","doi-asserted-by":"crossref","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799\u2013806.","DOI":"10.1513\/AnnalsATS.202008-1002OC"},{"key":"1264_CR30","doi-asserted-by":"crossref","unstructured":"Buckland M, Galloway J, Nic Fhogartaigh C, Meredith L, Provine N, Bloor S, et al. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nature Communications. 2020;11(","DOI":"10.1038\/s41467-020-19761-2"},{"key":"1264_CR31","doi-asserted-by":"crossref","unstructured":"Camprub\u00ed D, Gaya A, Marcos MA, Mart\u00ed-Soler H, Soriano A, Mosquera MDM, et al. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir. Int J Infect Dis. 2021;104(379\u201381.","DOI":"10.1016\/j.ijid.2020.12.050"},{"issue":"3","key":"1264_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/infdis\/jiab248","volume":"224","author":"R Aviv","year":"2021","unstructured":"Aviv R, Weber A, Anzum T, Federbush M, Horowitz D, Singas E. Prolonged coronavirus disease 2019 in a patient with rheumatoid arthritis on rituximab therapy. J Infect Dis. 2021;224(3):557\u20139.","journal-title":"J Infect Dis"},{"issue":"7","key":"1264_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa2031304","volume":"384","author":"VA Simonovich","year":"2021","unstructured":"Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, V\u00e1zquez C, et al. A randomized trial of convalescent plasma in covid-19 severe pneumonia. N Engl J Med. 2021;384(7):619\u201329.","journal-title":"N Engl J Med"},{"key":"1264_CR34","doi-asserted-by":"crossref","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGEN-COV antibody combination and outcomes in outpatients with covid-19. N Engl J Med. 2021;","DOI":"10.1056\/NEJMoa2108163"},{"issue":"8","key":"1264_CR35","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.jaip.2020.06.046","volume":"8","author":"E Mira","year":"2020","unstructured":"Mira E, Yarce OA, Ortega C, Fern\u00e1ndez S, Pascual NM, G\u00f3mez C, et al. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. J Allergy Clin Immunol Pract. 2020;8(8):2793\u20135.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1264_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","volume":"148","author":"OM Delmonte","year":"2021","unstructured":"Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, et al. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021;148(5):1192\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1264_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","volume":"148","author":"D Hagin","year":"2021","unstructured":"Hagin D, Freund T, Navon M, Halperin T, Adir D, Marom R, et al. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clin Immunol. 2021;148(3):739\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"1264_CR38","doi-asserted-by":"crossref","unstructured":"Chauvineau-Grenier A, Bastard P, Servajean A, Gervais A, Rosain J, Jouanguy E, et al. Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French Hospital. J Clin Immunol. 2022;1\u201312.","DOI":"10.21203\/rs.3.rs-915062\/v1"},{"issue":"8","key":"1264_CR39","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10875-021-01136-x","volume":"41","author":"X Solanich","year":"2021","unstructured":"Solanich X, Rigo-Bonnin R, Gumucio VD, Bastard P, Rosain J, Philippot Q, et al. Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona. J Clin Immunol. 2021;41(8):1733\u201344.","journal-title":"J Clin Immunol"},{"key":"1264_CR40","doi-asserted-by":"crossref","unstructured":"Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Renkilaraj MRLM, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Science Immunology. 2021;6(62):eabl4348.","DOI":"10.1126\/sciimmunol.abl4348"},{"key":"1264_CR41","unstructured":"Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6(62):"},{"key":"1264_CR42","doi-asserted-by":"crossref","unstructured":"Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, et al. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs impact of nasal IFN-I autoantibodies in COVID-19. Journal of Experimental Medicine. 2021;218(10):","DOI":"10.1084\/jem.20211211"},{"key":"1264_CR43","doi-asserted-by":"crossref","unstructured":"Bastard P, Orlova E, Sozaeva L, L\u00e9vy R, James A, Schmitt MM, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021;218(7):","DOI":"10.1084\/jem.20210554"},{"key":"1264_CR44","unstructured":"Zhang Q, Bastard P, Liu Z, Pen JL, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01264-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T16:12:34Z","timestamp":1727021554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01264-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IPINet registry and related informed consent forms have been approved by Institutional Ethics Committee (No 25\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All parents\/patients provided informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The informed consent included the authorization to publish information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}